PharmaXcelerate – Building Resilient Pharma, Biotech Facilities & Quality Systems will take place on 18–20 January 2027 in Dubai, UAE, bringing together senior pharmaceutical and biotech professionals, manufacturing and quality leaders, engineering experts, regulators and solution providers from across the region and beyond.
The event will focus on the future of resilient, compliant and efficient pharmaceutical manufacturing, with key discussions covering facility design and engineering, cleanroom and aseptic manufacturing, manufacturing excellence, technology transfer, AI and automation, digital validation, data integrity, GMP compliance, quality systems, commissioning and qualification, and sustainable operations.
PharmaXcelerate will feature senior representatives from leading organizations including Merck, Takeda, Novartis, Johnson & Johnson, Lonza, Novo Nordisk, CSL Behring, Terumo Pharmaceutical Services, Jamjoom Pharma, Hikma Pharmaceuticals, Eurofins BioPharma, Exyte and Sika, alongside regional industry leaders and pharmaceutical authorities.
The summit will provide a platform for meaningful discussions around the evolving MENA pharmaceutical landscape, regional manufacturing capabilities, localization, regulatory developments, digital transformation and the development of future-ready pharma and biotech facilities.
Organizer: TBM Group
Website: https://pharmaxcelerate.net/
Event page: tbmgroup.eu